Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
NCT04246021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2022-01-04
Summary
This study is a nonrandomized, single arm, open-label study stratified by iron-deficiency status.
Conditions
Interventions
- DRUG
-
Ferric carboxymaltose (FCM)
intravenous iron formulation
Sponsors & Collaborators
-
Hikma Pharmaceuticals LLC
collaborator INDUSTRY -
King Hussein Cancer Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-15
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
NCT07337460 ·Status: RECRUITING ·Phase: PHASE2
-
Huaier Granule in Treating Women With Triple Negative Breast Cancer
NCT02615457 ·Status: RECRUITING ·Phase: PHASE4
-
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00283478 ·Status: COMPLETED ·Phase: NA
-
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
NCT04710290 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC
NCT06900478 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
NCT00137761 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
NCT07243691 ·Status: RECRUITING ·Phase: NA
-
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
NCT05744219 ·Status: RECRUITING ·Phase: PHASE3
-
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063 ·Status: RECRUITING ·Phase: PHASE4
-
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
NCT00149565 ·Status: COMPLETED ·Phase: PHASE3
-
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)
NCT01448668 ·Status: UNKNOWN
-
Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence
NCT07328828 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.
NCT07206017 ·Status: RECRUITING ·Phase: NA
-
Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer
NCT02948309 ·Status: COMPLETED ·Phase: PHASE3
-
EGCG for Hepatocellular Carcinoma Chemoprevention
NCT06015022 ·Status: RECRUITING ·Phase: PHASE2
-
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
NCT04513028 ·Status: RECRUITING ·Phase: NA
-
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
NCT00562666 ·Status: TERMINATED ·Phase: PHASE1
-
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
NCT01681446 ·Status: UNKNOWN ·Phase: PHASE3
-
Recurrence in Buccinator Muscle Excision With the Skin Versus Without the Skin in Buccal Squamous Cell Carcinoma
NCT03364166 ·Status: UNKNOWN ·Phase: NA
-
Iscar for Supplemental Care in Stage IV Lung Cancer
NCT00079794 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
NCT01964001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Prospective Dose Finding Study of Iscador Infusion
NCT04376931 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Iressa Study in Patients With Salivary Gland Cancer
NCT00509002 ·Status: COMPLETED ·Phase: PHASE2
-
Isolation and Characterization of Cancer Stem Cells Using iFP Technique
NCT01641003 ·Status: UNKNOWN
-
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
NCT03984214 ·Status: COMPLETED ·Phase: PHASE3